What To Know About Zuranolone—The First FDA-Approved Oral Pill For Postpartum Depression

Forbes August 5, 2023
Ty Roush

Topline

The Food and Drug Administration approved a medication intended to treat postpartum depression on Friday, the first oral treatment to treat the depressive disorder that affects an estimated one in seven women after childbirth.

Key Facts

Crucial Quote

Samantha Meltzer-Brody, director of the Center For Women’s Mood Disorders at the University of North Carolina at Chapel Hill, told the Washington Post the drug “is going to be a game changer for treating maternal depression.”

Big Number

500,000. That’s the estimated number of women in the U.S. that experience symptoms of postpartum depression each year, according to Postpartum Support International.

Key Background

Postpartum depression—often referred to as “baby blues”—is experienced by some women after childbirth, though most tend to...

Today's Sponsors

Today's Sponsor